CRISM Therapeutics Corporation (AMMCF) Discusses Progress in ChemoSeed Drug Delivery Platform and Upcoming Brain Tumor Clinical Trial Transcript
Source: SeekingAlpha
2025-12-11 15:53:00 ET
CRISM Therapeutics Corporation (AMMCF) Discusses Progress in ChemoSeed Drug Delivery Platform and Upcoming Brain Tumor Clinical Trial December 11, 2025 7:00 AM EST...
Read the full article on Seeking Alpha
For further details see:
CRISM Therapeutics Corporation (AMMCF) Discusses Progress in ChemoSeed Drug Delivery Platform and Upcoming Brain Tumor Clinical Trial Transcript
Amur Minerals Corp Ord
NASDAQ: AMMCF
AMMCF Trading
0.0% G/L:
$0.0423 Last:
10,000 Volume:
$0.0423 Open:
